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Short-term forecasts of infectious disease can aid situational awareness and planning for outbreak 
response. Here, we report on multi-model forecasts of Covid-19 in the UK that were generated at 
regular intervals starting at the end of March 2020, in order to monitor expected healthcare 




We evaluated the performance of individual model forecasts generated between 24 March and 14 
July 2020, using a variety of metrics including the weighted interval score as well as metrics that 
assess the calibration, sharpness, bias and absolute error of forecasts separately. We further 
combined the predictions from individual models into ensemble forecasts using a simple mean as 
well as a quantile regression average that aimed to maximise performance. We compared model 




In most cases, individual models performed better than the null model, and ensembles models were 
well calibrated and performed comparatively to the best individual models. The quantile regression 




Ensembles of multi-model forecasts can inform the policy response to the Covid-19 pandemic by 
assessing future resource needs and expected population impact of morbidity and mortality. 
 
Introduction 
Since the first confirmation of a case on 31 January 2020, the Covid-19 epidemic in the UK has 
caused a large burden of morbidity and mortality. Following a rapid increase in cases throughout 
February and March, triggered by repeated introduction and subsequent local transmission ​1​, the UK 
population was advised on 16 March to avoid non-essential travel and contact with others, and to 
work from home if possible. This advice became enforceable law a week later, which was followed 
by a decline in reported cases and deaths starting in the first half of April. During the same period, 
hospitals prepared for a rapid increase in seriously ill patients by maximising inpatient and critical 
care capacity​2​. 
 
Short-term forecasts of infectious diseases are increasingly being used to inform public health policy 
for a variety of diseases ​3​. Models for short-term forecasts can be statistical (investigating the 
changing distribution of variables over time), mechanistic (explicitly incorporating plausible 
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biological and social mechanisms of transmission), or a hybrid of the two. While the best choice of 
models for short-term infectious disease forecasts is an ongoing topic of research, there  is some 
evidence that introducing mechanistic assumptions does not necessarily improve short-term 
predictive performance compared to statistical models that have no specific assumptions related to 
the disease transmission process ​4​. While short-term forecasts are most prominent for seasonal 
influenza, more recently they have also been made for outbreaks such as Ebola, measles, Zika, and 
diphtheria ​5–9​. Developing accurate and reliable short-term forecasts in real time for novel infectious 
agents such as SARS-CoV-2 in early 2020 is particularly challenging because of uncertainty about 
modes of transmission, severity profiles and other relevant parameters ​7,10​. 
 
Here, we report on short-term forecasts of the Covid-19 epidemic produced by six groups in the UK, 
representing a mixture of academic and government institutions and using a variety of models and 
methods. A system for collating and aggregating these forecasts was set up through a short-term 
forecasting subgroup of the Scientific Pandemic Influenza Group on Modelling (SPI-M) on 23 March, 
2020. The aim of these efforts was to predict the burden on the healthcare system, as well as key 
indicators of the current status of the epidemic faced by the UK at the time. Aggregate forecasts 
were made available to the Strategic Advisory Group of Experts (SAGE) and the UK government, 
marking the first time that a multitude of models for short-term forecasting models were explicitly 
combined to inform health policy in the UK. We review forecasts between the end of March and July 
and assess the quality of the predictions made at different times. 
Methods 
Targets and validation datasets 
Initially seven forecasting targets were set: 1) The number of intensive care unit (ICU) beds occupied 
by confirmed Covid-19 patients, 2) the total number of beds (including ICU) occupied by confirmed 
Covid-19 patients, 3) the total number of deaths by date of death, 4) the number of deaths in 
hospitals by date of report, 5) the number of new and newly admitted confirmed Covid-19 patients 
in hospital, 6) the number of new admissions to ICU and 7) the cumulative number of infections.  
 
Validation data sets for England and the seven English National Health Service (NHS) regions into 
which it is divided were derived from NHS England situational reports, and for the devolved nations 
in Northern Ireland, Scotland and Wales from their distinct reports and data sets. Because of 
differences in the structure of these reports and the data included in them, validation data sets 
started being used for the short-term forecasts at different times. Over time, this was reduced to 
four targets: the number of ICU beds and any beds occupied by confirmed Covid-19 patients, 
respectively; the number of new and newly admitted Covid-19 patients in hospital; and the number 
of deaths by date of death. Data sources and their interpretation changed at several points and 
definitions were updated as time progressed. Data sources that were not available at the time 
forecasts were made were excluded from the evaluation. 
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Forecasts 
Starting on 24 March 2020, modelling teams produced probabilistic forecasts for every day three 
weeks ahead for all targets except the cumulative number of infections, for which only a single time 
point at the date of report (i.e., a nowcast) was produced. Initially, teams submitted forecasts three 
times a week (with deadlines on Sunday, Tuesday and Thursday nights) and provided a best 
predicted estimate with lower and upper bounds of each forecast metric. On 31 March, this was 
changed to the median, 1%, 5%, 25%, 75%, 95% and 99% predictive quantiles. On 14 April it was 
decided to change to a schedule of submission twice a week (Sundays and Wednesdays, with an 
initial submission on a Thursday), and on 18 April the prediction quantiles were changed to 5% 
intervals from 5% to 95%. On 25 May the submission was changed to weekly on Tuesday mornings. 
Models 
The number of models providing forecasts changed over time, with 11 models from six institutions 
used from the end of March. Some of these 11 models were only used on a few occasions owing to 
the time required in producing forecasts at regular time intervals along with shifting priorities. Other 
models were changed over time as discussions over the nature of the validation data sets evolved 
and more information became available about the intricacies of the data used to model the 
epidemic. One of the models (NHSBHM) was purely statistical, one a statistical/mechanistic hybrid 
(EpiSoon) and all others mechanistic. In brief, the models used were: 
 
NHSBHM ​: A statistical Bayesian hierarchical model fitted individually to ICU and hospital admissions 
data to produce forecasts at the level of individual health trusts. The growth (decay) of the recorded 
values in each trust were assumed to follow a negative binomial distribution, whose mean was 
parameterised as a generalised logistic growth (decay) function. These forecasts were then 
aggregated to the regional and national level. 
  
Microsimulation ​11​: A spatial microsimulation model of Covid-19 transmission, fitted to hospital 
prevalence and incidence and death data by region of Great Britain via a sweep over a 
multidimensional parameter grid of the basic reproduction number ​R​0​, seeding and infection timing 
and effectiveness. A posterior distribution is calculated via Monte-Carlo sampling based on the 
(assumed negative binomial) likelihood of each model run. 
 
SIRCOVID ​12​:​ An age-structured stochastic compartmental Susceptible-Exposed-Infectious-Recovered 
(SEIR)-type model incorporating hospital care-pathways and transmission within care homes. A 
Bayesian evidence synthesis approach is applied to fit the model to multiple regional data sources, 
namely: daily deaths in hospital- and non-hospital settings, ICU and general bed prevalence data, 
Pillar 2 Polymerase Chain Reaction (PCR) testing data and serological survey data from blood-donors. 
Particle Markov-chain Monte Carlo (MCMC) methods are used to sample from the joint posterior 
distribution of model parameters, including disease-severity and time-varying transmission rates, 
and epidemic trajectories. The future epidemic trajectories are then simulated via posterior 
predictive forecasting. 
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Exponential growth/decline ​13​: An exponential model based on assumed doubling/halving times, 
applied to daily hospital admission data to forecast future admissions, broken down by general 
hospitalisation and ICU. For each admission, the duration of hospitalisation is simulated from 
discretized Gamma distributions parameterised with published estimates of length of stay in 
ICU/non-ICU. Beds are counted for each day to derive bed occupancy in each. 
  
EpiSoon ​14​: A semi-mechanistic model that combines a time series forecasting model with an 
estimated trajectory of the time-varying reproduction number over time. Cases, hospitalisations and 
deaths are simulated forward separately using a renewal equation model. Changes in the 
reproduction number are estimated from probabilistic reconstruction of infection dates, separately 
for each geography. 
  
Transmission ​15​: An age-structured dynamic transmission model that uses Google mobility data to 
parameterize the impact of social distancing measures in each NHS region. The model is fitted to 
deaths and hospital bed occupancy in each region. 
  
DetSEIRwithNB ​16​:​ A deterministic SEIR-type model without age structure, but with differential rates 
between compartments depending on the next state individuals are progressing to (e.g. 
symptomatic cases recovering naturally or being admitted to hospital spend different times in their 
infectious state, reflecting different underlying progression processes). Infected cases can be 
asymptomatic or symptomatic, symptomatic cases recover or go to hospital, hospitalised cases 
recover, die or proceed to ICU, and ICU cases die or step down to hospital and then recover. The 
model fits new and newly confirmed cases in hospital, hospital and ICU beds occupied, and hospital 
deaths, using a negative binomial likelihood around the deterministic mean, to data for each region 
and nation independently. Transmission, and hence the reproduction number, are piecewise 
constant, with change points at the time of the lockdown (24 March), 1 month later (suggested by 
visual inspection of the data stream) and 6 weeks before the most recent data point.  Two different 
variants for the fitting procedures are employed, one based on Maximum Likelihood Estimation 
(MLE) and one on MCMC. 
 
Regional/age ​17​: An adaptation of a Bayesian modelling framework developed for pandemic 
influenza​18​, this approach combines parallel deterministic SEIR transmission and disease reporting 
models for each NHS region, fitted to age-specific death and serological data. The parallel regions 
are linked through common parameters for the infectious period and the IFR. The model outputs 
Bayesian posterior probability distributions for parameters of interest and predictive distributions 
for the trajectory of the epidemic.  
 
Secondary care ABC ​: A model which accounts for individuals admitted to ICUs and general hospital 
admissions, taking into consideration the potentially different timescales of fatality and recovery, 
fitted to hospital deaths, hospital admissions, ICU prevalence and hospital prevalence using 
Approximate Bayesian Computation Sequential Monte Carlo (ABC SMC). 
 
StructuredODE​19,20​: An age-structured model based on SEIR-type equations but extended to include 
symptomatic and asymptomatic individuals, and to account for household isolation and 
quarantining. Susceptibility, risk of symptoms, risk of hospitalisation and risk of death are all 
age-dependent and based on reported data for England. For the seven regions in England and the 
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three devolved nations (Wales, Scotland and Northern Ireland) solutions are matched to number of 
deaths (using date of death), hospital occupancy, ICU occupancy and hospital admissions; for 
England this is supplemented with serological data from blood donor sampling - this fitting 
procedure infers early growth and the strength of controls in each area as well as the appropriate 
scaling between symptomatic cases and observable health-care metrics.  
Assessment metrics 
We assessed weekly forecasts using the weighted average interval score (WIS) across all quantiles 
that were being gathered ​21​. This WIS is a strictly proper scoring rule, that is, it is optimised for 
predictions that come from the data-generating model and, as a consequence, encourages 
forecasters to report predictions representing their true belief about the future​22​. The WIS 
represents a parsimonious approach to scoring forecasts when only quantiles are available:  
 
 
It is a weighted average of the interval score ​22​ over  central  prediction intervals bounded 
by quantile levels , where  is an observed outcome,  the forecast,  the 
median of the predictive distribution, and  and  are the predictive upper and lower quantiles 
corresponding to the central predictive interval level , respectively. The interval score is optimised 
at 0, representing a point forecast which is exactly correct. It penalises wide prediction intervals as 
well as data that lies outside the intervals. 
 
We further assessed the calibration, sharpness and bias of forecasts separately, in line with the 
premise that forecasts should “maximise sharpness subject to calibration”, that is as narrow as 
possible while consistent with future observations ​22,23​. For calibration, we assessed coverage at the 





As bias metric, we estimates the proportion of predictive probability mass below/above the 
observation using the discrete quantiles, approximating a previously defined bias metric​23​, 
 
 
where we define the outermost quantiles corresponding to  as  and ​. 
 
We lastly compared weekly forecasts by the mean absolute error (MAE) of the median forecast. 
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Ensembles 
We combined all the model forecasts into a single ensemble using two stacking procedures, with the 
aim to compare them in order to select an optimum procedure. Firstly, we produced an ensemble 
with equally-weighted quantiles (EWQ) by calculating each combined quantile as the mean or 
median of all the individual model predictive quantiles ​24,25​. Secondly, we generated an ensemble 
using quantile regression averaging (QRA) to calculate each combined quantile as a weighted 
average of the individual model quantiles for each location and metric, where weights were 
estimated from past data to optimise past performance with respect to the one-week ahead WIS ​26,27​. 
We tested a range of past data from 1 to 5 weeks to include in QRA, and several variants of this 
procedure, including constraining the weights to be non-negative and sum up to one or not, 
estimating weights per quantile (with an additional constraint to avoid quantile crossing) or one 
weight across quantiles, estimating common weights for NHSE regions or separate weights, and 
having an intercept in the regression or not. Weights were calculated using the ​quantgen​ R 
package ​28​. 
Null model 
We compared the performance of both the individual models and the ensembles with a null model 
that assumed that each target would stay at its current value indefinitely into the future, with 
uncertainty levels given by a discretised truncated normal distribution with lower bound 0 and a 
standard deviation given by past one-day ahead deviations from the value of the metric. 
Results 
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Figure 1: Median weekly 7-day ahead forecasts of each individual model for selected targets 
across the four nations of the UK (only publicly available data shown). Forecasts are shown 
on the day for which the forecast was made a week earlier (dots: median; whiskers: 90% 
prediction intervals; one colour per model) and compared to the observations (black lines). 
Data sources are marked in grey where they were not available at the time of the forecasts. 
 
The initial forecasts were made just before the peak in confirmed Covid-19 hospital 
occupancy in early April. The 11 models were used to provide a total of 71,887 predicted 
days across the four final forecast targets and different geographies, during the 13 weeks up 
to 14 July 2020 or 8 weeks up to 9 June 2020 (for new and newly confirmed patients in 
hospital), respectively. Overall, the individual models broadly followed the trajectory of the 
epidemic in their forecasts but struggled to correctly predict the timing and height of the peak 
in early April (Fig. 1). Almost all individual models performed consistently better than the null 
model (no change) in median predictions at a 2 week horizon, but less clearly so at a 1 week 
horizon, when a model null model of no change sometimes outperformed individual models 




Figure 2: Performance against a null model of no change, shown as the proportion of 1-week 
and 2-week forecasts of each model that performed better than the null model with respect 
to the WIS (dots: proportion; lines: 95% binomial confidence intervals). Only models that 
were used to make forecasts at more than 2 time points are shown. Data sources are 
marked in grey where they were not available at the time of the forecasts. 
 
While there was little consistency amongst the models with respect to performance against 
the four targets considered and no model clearly outperforming the others, all the ensemble 
models considered performed as good as or better than the best individual models against 
each target with respect to the WIS (Fig. 2 and Table 1). The best-performing QRA 
 . CC-BY 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted December 4, 2020. ; https://doi.org/10.1101/2020.11.11.20220962doi: medRxiv preprint 
ensemble according to the WIS used only the latest set of historical forecasts to estimate the 
weights and assigned separate weights for each quantile and each geographical region, 
constrained to sum up to 1 and without intercept (Supplementary Table S2). The 
best-performing EWQ combined models by taking the median of quantiles at each quantile 
level (Supplementary S3). Compared to the equal-weighted ensemble, the best-performing 




Table 1: Performance of the ensemble models (n: number of weeks for which forecasts were 
generated) with respect to calibration, shown as the coverage at the 50% and 90% level 
(Cov 0.5 and Cov 0.9, respectively), bias, sharpness (Sharp), WIS and MAE of the median. 
A well calibrated model would have 0.5 coverage at the 50% level and 0.9 coverage at the 
90% level and a bias of zero. Models making narrower predictions have lower values of the 
sharpness metric, and models that are closer to the truth have lower WIS and MAE. 
 
 
Figure 3: Weekly 7-day ahead forecasts of the ensemble models for selected targets across 
the four nations of the UK (only publicly available data shown, and only ensembles 
comprising more than one model). Forecasts are shown on the day for which the forecast 
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was made a week earlier (dots: median; whiskers: 90% prediction intervals) and compared 
to the data as subsequently observed (black lines). Data sources are marked in grey where 
they were not available at the time of the forecasts. 
 
Both the ensemble methods yielded well-calibrated models for daily deaths and new and newly 
confirmed cases in hospital at both 1-week and 2-week time horizons, but less so for hospital and in 
particular ICU occupancy (Table 1, Cov 0.5 and Cov 0.9). The forecasts were positively biased, i.e. 
overestimated ICU beds occupied as well as new and newly confirmed cases in hospital, while they 
were much less biased in either direction for total beds occupied and deaths (Table 1, Bias). The 
ensemble methods had similar sharpness, with the QRA model slightly sharper than the EWQ in 
most cases (Table 1, Sharp). Overall, the EWQ models performed better than most variants of the 
QRA in terms of both WIS and MAE, but the best QRA models tended to outperform the EWQ (Table 
1, WIS and MAE, and Supplementary Tables 2 and 3). The QRA as a model that could learn from past 
performance, gave widely fluctuating weights to models over time (Fig. 4). 
 
 
Figure 4: Weights given to the different models in the median prediction of the best-performing QRA 
at each forecast date for England. 
Discussion 
A system for collating and combining short-term forecasts was set up during the early phase of the 
Covid-19 epidemic in the UK as a response to an urgent need for predictions of the epidemic 
trajectory and health system burden. This led to rapid model building and left little time for 
systematic testing. The results shown here highlight some of the challenges in predicting an 
emerging epidemic, where calibration and predictive performance are difficult to achieve and 
considerable uncertainties exist ​10,23,29​. The forecasts reflect a large variation in models that had been 
designed for a variety of purposes and, at least in some cases, rapidly adapted to the task. The 
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models have been and are being developed and improved as additional information becomes 
available, both on the validation data sources and the properties of the epidemic. This makes it 
difficult to create like-for-like comparisons across different dates at which forecasts were made. 
 
Given these difficulties, it is important that models are synthesised in a meaningful and principled 
manner in order to derive greater value from different methodological perspectives on the 
epidemic. We found that stacking the models using a quantile regression average that optimises 
historical forecast performance resulted in good calibration against most targets and tended to 
outperform the equally-weighted quantile combination. Having said this, this result was based on 
testing a wide range of ways to combine models in a quantile regression, and only the 
best-performing variants performed better than a simple equal-weighted quantile average, which in 
turn performed better than most individual models. It has been observed in other fields that a 
simple model average tends to outperform individual models, which can, to some degree, be 
explained theoretically​30​. 
 
Over the three months analysed here, the models, as well as the inclusion and interpretation of the 
different data sources, were undergoing continuous change. At the same time, not every model was 
submitted every week due to the time pressures involved and shifting priorities in a rapidly evolving 
public health emergency. The lack of significant improvement from weighting by past forecast 
performance would indicate that these issues change the performance of the individual models on a 
week-by-week basis, potentially to a degree that reduces the expected benefits from systematically 
taking into account the past performance of each model. For these reasons, the model combination 
produced from the equally weighted quantiles can serve as a good and principled ensemble forecast, 
while the performance of different ensemble methodologies remains an ongoing topic of 
investigation.  
 
Throughout the period investigated in this study, the epidemic in the UK steadily declined, and good 
performance in this period need not correlate with good performance in other regimes, such as a 
resurgence of cases or a steady-state behaviour. The difficulty of the models to correctly predict the 
turnaround of the epidemic around the peak (albeit often acknowledging their own uncertainty) 
indicates that there may be value in incorporating external information, e.g. from changing social 
contact studies or behavioural surveys ​31,32​. All models received some weight in the QRA at least 
during some periods, indicating that there is value in the contributions of all of the models. 
Extensions to the simple regression used here​33​, or alternatives such as isotonic distributional 
regression ​34​, may yield future performance gains, as may the inclusion of model types and structures 
that are currently not represented in the pool of models that are part of the ensemble. 
 
Much discussion on real-time modelling to inform policy has focused on the value of the 
reproduction number, ​R​. A real-time estimate of ​R​ indicates whether new infections are expected to 
increase or decrease and is, therefore, a valuable quantity to signal the need for control measures 
and their required strength. However, it does not provide a direct prediction of the estimated 
burden on the healthcare system or expected morbidity and mortality in the near future. By 
forecasting these directly, decision makers can be equipped with a more complete set of indicators 
for short-term planning than through considering ​R​ alone. Unlike scenario models, which are a key 
tool for long-term planning but are difficult to validate rigorously because of unsurmountable 
long-term uncertainty, modelling for short-term forecasts can be numerically evaluated and, 
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consequently, improved in real-time. Conversely, models that are optimised for short-term forecasts 
usually decline in predictive performance after only a few generations of transmission ​23​. Together, 
these two types of modelling have played a key role in informing the response to the Covid-19 
pandemic in the UK and elsewhere. 
 
As SARS-CoV-2 continues to spread in populations around the world, real time modelling and 
short-term forecasting can be key tools for short-term resource planning and pandemic 
management. The short-term forecasts described here and related initiatives in the US ​35​, Germany 
and Poland ​36​, and elsewhere are reflecting efforts to provide decision makers with the information 
they need to make informed decisions. In the UK, similar methodologies to the ones presented here 
are now used to generate medium-term projections, that is extrapolations over time periods longer 
than three weeks of what would be expected to happen if nothing changed from the current 
situation. As SARS-CoV-2 continues to affect populations around the world, short-term forecasts and 
longer-term projections can play a crucial part in real-time monitoring of the epidemic and its 
expected near-term impact in morbidity, healthcare utilisation and mortality. 
Code and data availability 
All code and data used to generate the results in this paper are available as an R package at 
https://github.com/epiforecasts/covid19.forecasts.uk​.  
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Supplementary Table S1: Individual model 
performance 
 
Supplementary Table S1: Performance of individual models (n: number of weeks for which 
the model was used to contribute short-term forecasts) with respect to calibration, shown as 
the coverage at the 50% (Cov 0.5) and 90% level (Cov 0.9), bias, sharpness (Sharp), WIS 
and MAE. A well calibrated model would have 0.5 coverage at the 50% level and 0.9% 
coverage at the 90% level and a bias of zero. Models making narrower predictions have 
lower sharpness, and models that are closer to the truth have lower WIS and MAE. Note that 
performances between models are not directly comparable because they cover varying time 
periods. 
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Supplementary Table S2: Performance of all permutations of QRA models with respect to 
the WIS. Model options were: the number of previous forecasts (history) to include in the 
regression, whether to force the weights to be non-negative and sum to 1, whether to model 
an intercept, whether to estimate separate weights by quantile, and whether to estimate 
separate weights by English region. 
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Supplementary Table S3: EWQ ensemble 
performance 
  
Supplementary Table S3: Performance of mean- and median-based EWQ models with 
respect to the WIS. 
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